Oppenheimer Asset Management Inc. Decreases Stock Position in Sarepta Therapeutics, Inc. (NASDAQ:SRPT)
Oppenheimer Asset Management Inc. decreased its stake in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 8.5% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 4,079 shares of the biotechnology company’s stock after selling 378 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Sarepta Therapeutics were worth $496,000 at […]
Oppenheimer Asset Management Inc. decreased its stake in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 8.5% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 4,079 shares of the biotechnology company’s stock after selling 378 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Sarepta Therapeutics were worth $496,000 at […]
